Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

1.62
Delayed Data
As of Feb 27
 -0.05 / -2.99%
Today’s Change
0.97
Today|||52-Week Range
2.12
-14.29%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Pykett Mark Jerome
Chief Executive Officer
Sale3/10/2014120,000$1.96$235.2K-20.20%
Platinum Management /ny/ Llc
Sale9/02/201460,000$1.36$81.6K+15.71%
Larson Brent L
Sale3/10/201441,500$1.96$81.3K-20.20%
Goldberg Michael M
Director
Buy11/13/201471,641$1.06$75.9K+47.27%
Larson Brent L
CFO, Secretary, Treasurer & EVP
Sale12/10/201426,947$1.31$35.3K+25.58%
Goldberg Michael M
Director
Buy11/14/201428,359$1.12$31.8K+39.66%
Cope Frederick O
Senior Vice President
Sale3/10/201415,000$1.96$29.4K-20.20%
Larson Brent L
Sale3/10/201412,312$1.99$24.5K-20.20%
Larson Brent L
Buy3/10/201450,000$0.49$24.5K-20.20%
Troup Gordon A
Director
Gift11/10/201416,099$1.32$21.3K+57.28%
Page of 3

To view my watchlist

Not a member yet?

Sign up now for a free account